Sotorasib

Sotorasib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82712-2 5 mg - - -

3 - 15 business days*

367.00€
BPS-82712-1 1 ml (10 mM (DMSO)) - - -

3 - 15 business days*

410.00€
BPS-82712-3 10 mg - - -

3 - 15 business days*

528.00€
BPS-82712-4 25 mg - - -

3 - 15 business days*

848.00€
 
Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent... more
Product information "Sotorasib"
Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors1,2.
Keywords: KRAS G12C inhibitor, Sotorasib, AMG-510,
Supplier: BPS Bioscience
Supplier-Nr: 82712

Properties

Application: Ras signaling, cancer therapy target
MW: 560,59 D
Formula: C30H30F2N6O3

Database Information

CAS : 2296729-00-3| Matching products
KEGG ID : K07827 | Matching products

Handling & Safety

Storage: -80°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Sotorasib"
Write a review
or to review a product.
Viewed